Company / SG&A Expense
PACS Group, Inc. SG&A Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$415.1M
FY2025
5-year range
$149.0M / $415.1M
FY2022-FY2025
Trend
+20.7%
vs FY2024
Sector context
#77 of 158
Health Care
What the data says
At $415M, PACS Group, Inc.'s sg&a expense ranks #82 of 158 in the Health Care sector. SG&A Expense has increased for 3 consecutive years, from $149M in FY2022 to $415M in FY2025.
Based on SEC 10-K filings.
$415M in FY2025 with a 3-year CAGR of +40.7%.
Increased from $214M to $415M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +40.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#82 of 158 in Health CareTop 51% of 158This company $415.1M Sector average $175.9B
▼
-99.8% below sector average
Key checks
Key Insights
- PACS Group, Inc.'s sg&a expense has grown for 3 consecutive years.
- 3-year CAGR of +40.7%, indicating consistent growth.
- In FY2025, sg&a expense increased 20.7% year-over-year.
- Ranks #77 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $415.1M | +20.7% |
| FY2024 | $343.8M | +60.9% |
| FY2023 | $213.7M | +43.4% |
| FY2022 | $149.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026